Singlomics - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $79,653.80 +4.32%
Ethereum $3,200.65 +5.37%
BNB $634.06 +2.72%
Optimism $1.70 +6.15%
Arbitrum $0.64 +7.19%
Solana $208.66 +5.38%
Polygon $0.41 +8.88%
Cosmos $5.34 +14.13%
Avalanche $31.97 +11.30%

Bitcoin $79,653.80 +4.32%
Ethereum $3,200.65 +5.37%
BNB $634.06 +2.72%
Optimism $1.70 +6.15%
Arbitrum $0.64 +7.19%
Solana $208.66 +5.38%
Polygon $0.41 +8.88%
Cosmos $5.34 +14.13%
Avalanche $31.97 +11.30%

Singlomics

company

Summary
Funding Rounds
Investors

About

Singlomics uses single-cell sequencing technology for antibody drug discovery.

Highlights

Total Funding Amount

Details

Last Funding Type: Series B
Last Funding Money Raised: ¥300M
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 2020
Operating Status: Active

Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥300M

Singlomics has raised a total of ¥300M in funding over 2 rounds. Their latest funding was raised on Feb 2, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Feb 2, 2022	Series B	¥300M	3	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

3

Singlomics is funded by 3 investors. JIANYI CAPITAL and Witruth Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
JIANYI CAPITAL	—	Series B
Witruth Capital	—	Series B
Ruihua Venture Capital	—	Series B